These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1327509)
1. Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary results. Levine AM; Shibata D; Sullivan-Halley J; Nathwani B; Brynes R; Slovak ML; Mahterian S; Riley CL; Weiss L; Levine PH Cancer Res; 1992 Oct; 52(19 Suppl):5482s-5484s. PubMed ID: 1327509 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Haque AK; Myers JL; Hudnall SD; Gelman BB; Lloyd RV; Payne D; Borucki M Mod Pathol; 1998 Apr; 11(4):347-56. PubMed ID: 9578085 [TBL] [Abstract][Full Text] [Related]
3. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. Pallesen G; Hamilton-Dutoit SJ; Rowe M; Lisse I; Ralfkiaer E; Sandvej K; Young LS J Pathol; 1991 Dec; 165(4):289-99. PubMed ID: 1664459 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003 [TBL] [Abstract][Full Text] [Related]
5. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders. Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167 [TBL] [Abstract][Full Text] [Related]
7. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607 [TBL] [Abstract][Full Text] [Related]
9. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591 [TBL] [Abstract][Full Text] [Related]
10. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996 [TBL] [Abstract][Full Text] [Related]
14. How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? Diamond C; Taylor TH; Im T; Wallace M; Saven A; Anton-Culver H Cancer Causes Control; 2007 Mar; 18(2):135-42. PubMed ID: 17235495 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
17. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778 [TBL] [Abstract][Full Text] [Related]
18. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. Meeker TC; Shiramizu B; Kaplan L; Herndier B; Sanchez H; Grimaldi JC; Baumgartner J; Rachlin J; Feigal E; Rosenblum M AIDS; 1991 Jun; 5(6):669-74. PubMed ID: 1652978 [TBL] [Abstract][Full Text] [Related]